Real-life Vaccination Coverage in Slovak Children with Rheumatic Diseases

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2022 Aug 29

PMID 36034574

Authors

Barbora Balaziova

Zuzana Kukova

Dasa Misikova

Katarina Novosedlikova

Tomas Dallos

Affiliations

Soon will be listed here.

Abstract

Background: Evidence-based recommendations for vaccination of patients with pediatric rheumatic diseases (PRDs) are available, their implementation in practice is unknown.

Objectives: To analyze real-life vaccination coverage in children with PRDs and identify reasons for incomplete vaccination.

Methods: Up-to-date information on vaccination status of Slovak children followed at a tertiary pediatric rheumatology center was retrieved from pediatricians over an 18-month period and compared to the standard Slovak Immunization Schedule. Reasons for missed vaccinations were analyzed retrospectively.

Results: Vaccination records of 156 patients (median age 10 years, 2-18) with PRDs (JIA = 108, systemic diseases = 21, autoinflammatory diseases = 16, uveitis = 9, others = 2) were available for analysis. 117 (75.0%) were completely vaccinated, 2 (1.3%) had not received any vaccine due to reasons unrelated to PRD. 37 (23.7%) remaining patients missed altogether 48 mandatory vaccinations. In 58.3% ( = 28, in 24 patients) no PRD related reasons for missing vaccinations were identified. Only 20 vaccinations (18 live-attenuated and 2 non-live in 19 patients) were missed due to ongoing immunosuppressive treatment or PRD activity. Patients aged 11-14 years were more likely to be incompletely vaccinated than other age groups (48.8% vs. 15.9%, < 0.001), mainly due to missed MMR booster. Systemic immunosuppressive treatment was a significant predictor for incomplete vaccination status (OR 5.03, 95% CI 1.13-22.31, = 0.03).

Conclusion: Full vaccination is possible in a high proportion of PRD patients. In addition to immunosuppressive therapy, reasons unrelated to PRDs are a frequent and possibly inadequate cause of missed vaccinations. Periodic vaccination status assessments are needed in pediatric rheumatology care.

Citing Articles

Hepatitis B vaccine and juvenile idiopathic arthritis: comparison of the seropositivity rates with healthy children at the time of diagnosis and booster dose response under treatment.

Iseri Nepesov M, Gur G, Yamanel R, Cakan M Clin Rheumatol. 2025; 44(3):1299-1305.

PMID: 39808236 DOI: 10.1007/s10067-025-07313-2.

Influenza vaccine uptake in juvenile idiopathic arthritis: a multi-centre cross-sectional study.

Maritsi D, Dasoula F, Ziv A, Bizjak M, Balaziova B, Matosevic M Eur J Pediatr. 2024; 183(7):2937-2944.

PMID: 38619568 PMC: 11192805. DOI: 10.1007/s00431-024-05552-0.

Parents' Uptake and Willingness towards Recommended Vaccinations for Their Children with Underlying Chronic Medical Conditions in Italy.

Della Polla G, Miraglia Del Giudice G, Postiglione M, Angelillo I Vaccines (Basel). 2023; 11(9).

PMID: 37766100 PMC: 10536001. DOI: 10.3390/vaccines11091423.

Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data.

Makarova E, Khabirova A, Volkova N, Gabrusskaya T, Ulanova N, Sakhno L World J Clin Pediatr. 2023; 12(2):45-56.

PMID: 37034429 PMC: 10075019. DOI: 10.5409/wjcp.v12.i2.45.

References

Olivieri B, Betterle C, Zanoni G . Vaccinations and Autoimmune Diseases. Vaccines (Basel). 2021; 9(8). PMC: 8402446. DOI: 10.3390/vaccines9080815. View

Hiraki L, Feldman C, Marty F, Winkelmayer W, Guan H, Costenbader K . Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid. Arthritis Care Res (Hoboken). 2017; 69(11):1620-1626. PMC: 5563276. DOI: 10.1002/acr.23219. View

Grein I, Groot N, Lacerda M, Wulffraat N, Pileggi G . HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know. Pediatr Rheumatol Online J. 2016; 14(1):12. PMC: 4782298. DOI: 10.1186/s12969-016-0072-x. View

Sousa S, Duarte A, Cordeiro I, Ferreira J, Goncalves M, Meirinhos T . Efficacy and Safety of Vaccination in Pediatric Patients with Systemic Inflammatory Rheumatic Diseases: a systematic review of the literature. Acta Reumatol Port. 2017; 42(1):8-16. View

Morin M, Quach C, Fortin E, Chedeville G . Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology (Oxford). 2012; 51(11):2046-50. DOI: 10.1093/rheumatology/kes175. View

Harris J, Maletta K, Ren B, Olson J . Improving Pneumococcal Vaccination in Pediatric Rheumatology Patients. Pediatrics. 2015; 136(3):e681-6. DOI: 10.1542/peds.2014-2512. View

Rondaan C, Furer V, Heijstek M, Agmon-Levin N, Bijl M, Breedveld F . Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations. RMD Open. 2019; 5(2):e001035. PMC: 6744079. DOI: 10.1136/rmdopen-2019-001035. View

Beukelman T, Xie F, Chen L, Baddley J, Delzell E, Grijalva C . Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012; 64(8):2773-80. PMC: 3409300. DOI: 10.1002/art.34458. View

Beukelman T, Xie F, Baddley J, Chen L, Delzell E, Grijalva C . Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum. 2013; 65(5):1384-9. PMC: 3636167. DOI: 10.1002/art.37866. View

10.

Giancane G, Swart J, Castagnola E, Groll A, Horneff G, Huppertz H . Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee. Arthritis Res Ther. 2020; 22(1):71. PMC: 7136994. DOI: 10.1186/s13075-020-02167-2. View

11.

Kroger A, Atkinson W, Marcuse E, Pickering L . General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006; 55(RR-15):1-48. View

12.

Furer V, Rondaan C, Heijstek M, Agmon-Levin N, van Assen S, Bijl M . 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2019; 79(1):39-52. DOI: 10.1136/annrheumdis-2019-215882. View

13.

Papailiou S, Markade A, Eleftheriou I, Tsolia M, Garoufi A, Maritsi D . A National Survey Across Primary Care Pediatricians Regarding Immunization Views and Practices in Children With Rheumatic Diseases. J Clin Rheumatol. 2020; 27(8):e588-e590. DOI: 10.1097/RHU.0000000000001251. View

14.

Hussain A, Ali S, Ahmed M, Hussain S . The Anti-vaccination Movement: A Regression in Modern Medicine. Cureus. 2018; 10(7):e2919. PMC: 6122668. DOI: 10.7759/cureus.2919. View

15.

Bizjak M, Blazina S, Zajc Avramovic M, Markelj G, Avcin T, Toplak N . Vaccination coverage in children with rheumatic diseases. Clin Exp Rheumatol. 2019; 38(1):164-170. View

16.

Remy V, Zollner Y, Heckmann U . Vaccination: the cornerstone of an efficient healthcare system. J Mark Access Health Policy. 2016; 3. PMC: 4802703. DOI: 10.3402/jmahp.v3.27041. View

17.

Kostik M, Lubimova N, Fridman I, Goleva O, Kharit S . The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study. Pediatr Rheumatol Online J. 2021; 19(1):108. PMC: 8256221. DOI: 10.1186/s12969-021-00594-2. View

18.

Becker I, Horneff G . Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry. Arthritis Care Res (Hoboken). 2016; 69(4):552-560. DOI: 10.1002/acr.22961. View

19.

Higgins G . Complications of Treatments for Pediatric Rheumatic Diseases. Pediatr Clin North Am. 2018; 65(4):827-854. DOI: 10.1016/j.pcl.2018.04.008. View

20.

Maritsi D, Vartzelis G, Soldatou A, Garoufi A, Spyridis N . Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2013; 31(6):969-73. View